Roberto Hofmann is an Analyst at Forbion, which he joined in 2025.
Prior to Forbion, he co-founded a stealth biotech company in the protein degradation space in collaboration with TSL Ventures.
Roberto holds a PhD in Molecular Biology from the University of Cambridge and a BSc in Molecular Biology and Physics from University College London. Alongside his studies, he gained experience at McKinsey & Company and Equitas Capital.
